Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| De novo myelodysplastic syndrome in a Rothmund-Thomson Syndrome patient with novel pathogenic RECQL4 variants. | Blood Sci | 2023 | 37228773 | PubTator, text mining | PubMed |
| Telomerase-targeted therapies in myeloid malignancies. | Blood Adv | 2023 | 37216228 | PubTator, text mining | PubMed |
| The interplay between non-coding RNAs and alternative splicing: from regulatory mechanism to therapeutic implications in cancer. | Theranostics | 2023 | 37215575 | PubTator, text mining | PubMed |
| Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study. | EJHaem | 2023 | 37206258 | PubTator, text mining | PubMed |
| Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease. | J Am Coll Cardiol | 2023 | 37197843 | PubTator, text mining | PubMed |
| Toward a systems-level probing of tumor clonality. | iScience | 2023 | 37192968 | PubTator, text mining | PubMed |
| What's Next after Hypomethylating Agents Failure in Myeloid Neoplasms? A Rational Approach. | Cancers (Basel) | 2023 | 37190176 | PubTator, text mining | PubMed |
| Association between Immunophenotypic Parameters and Molecular Alterations in Acute Myeloid Leukemia. | Biomedicines | 2023 | 37189716 | PubTator, text mining | PubMed |
| RUNX1 mutation has no prognostic significance in paediatric AML: a retrospective study of the AML-BFM study group. | Leukemia | 2023 | 37188777 | PubTator, text mining | PubMed |
| Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group. | Blood Cancer J | 2023 | 37173322 | PubTator, text mining | PubMed |
| A randomized comparison of CPX-351 and FLAG-Ida in adverse karyotype AML and high-risk MDS: the UK NCRI AML19 trial. | Blood Adv | 2023 | 37171402 | PubTator, text mining | PubMed |
Clonal cytopenia of undetermined significance (CCUS)-associated reversion of donor-derived, transient αβ T-cell large granular clonal lymphocytosis, emerging post-transplant in a patient with a history of γδ T-cell large granular lymphocytic leukemia. | Cold Spring Harb Mol Case Stud | 2023 | 37160316 | PubTator, text mining | PubMed |
| Impact of Clonal Architecture on Clinical Course and Prognosis in Patients With Myeloproliferative Neoplasms. | Hemasphere | 2023 | 37153874 | PubTator, text mining | PubMed |
| TRA2: The dominant power of alternative splicing in tumors. | Heliyon | 2023 | 37151663 | PubTator, text mining | PubMed |
| Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general population. | Cancer Cell | 2023 | 37146604 | PubTator, text mining | PubMed |
| The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms. | Br J Haematol | 2023 | 37144345 | PubTator, text mining | PubMed |
| Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia. | Blood Adv | 2023 | 37142255 | PubTator, text mining | PubMed |
| Spatial profiling of the microenvironment reveals low intratumoral heterogeneity and STK11-associated immune evasion in therapy-naïve lung adenocarcinomas. | Lung Cancer | 2023 | 37141769 | PubTator, text mining | PubMed |
| Mouse nuclear RNAi-defective 2 promotes splicing of weak 5' splice sites. | RNA | 2023 | 37137667 | PubTator, text mining | PubMed |
| AML classification in the year 2023: How to avoid a Babylonian confusion of languages. | Leukemia | 2023 | 37120689 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=25